ACCESS HUB
LIVE

Serial Number

98493564

Owner

IPD Analytics, LLC

Attorney

Julie A. Greenberg

First Use Date

Feb 24, 2021

Filing Date

Apr 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ACCESS HUB Trademark

Serial Number: 98493564 • Registration: 8138417

ACCESS HUB is a trademark filed by IPD Analytics, LLC on April 10, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

IPD Analytics, LLC (24 trademarks)

Aventura, FL 33180

Entity Type: 16

Trademark Details

Filing Date

April 10, 2024

Registration Date

February 10, 2026

First Use Anywhere

February 24, 2021

First Use in Commerce

February 24, 2021

Published for Opposition

March 11, 2025

Goods & Services

Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs

Business and commercial pharmaceutical market analysis and information services; Gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the nature of providing business and commercial information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets in the nature of providing business and commercial information providing business information and market analysis services in the field of pharmaceuticals

Gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the nature of financial and insurance information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; providing financial and insurance information, data, and analytics in the nature of financial and insurance information in the field of pharmaceuticals and pharmaceutical markets; Financial analysis and insurance information services in the field of pharmaceutical markets

Medical information relating to medical, therapeutic, pharmacological, and pharmaceutical fields; Medical information and medical analysis relating to medical, therapeutic, pharmacological, and pharmaceutical fields for diagnostic and treatment purposes provided by medical laboratories; Gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the nature of medical information in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing medical research information in the field of pharmaceuticals

Gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the nature of providing scientific information and scientific research information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) featuring software for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics in the nature of providing scientific information and scientific research information regarding pharmaceuticals; Scientific and scientific research information analysis services in the nature of providing scientific information, scientific research information and scientific analysis in the field of pharmaceuticals; Software as a service (SAAS) featuring software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 28, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 28, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 28, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 20, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 20, 2026 CNPR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 20, 2026 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 14, 2026 EX1G
STATEMENT OF USE PROCESSING COMPLETE
Jan 14, 2026 SUPC
SOU EXTENSION 1 FILED
Nov 5, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2025 EEXT
USE AMENDMENT FILED
Jul 22, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 22, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 19, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 30, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2024 NWOS
NEW APPLICATION ENTERED
Apr 10, 2024 NWAP